WVE-N531

DRUG2 trials

Sponsors

Wave Life Sciences Ltd.

Conditions

Duchenne Muscular Dystrophy

Phase 1

Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)

RecruitingNCT04906460

Wave Life Sciences Ltd.Duchenne Muscular Dystrophy

Start: 2021-09-28End: 2027-04-24Target: 26Updated: 2025-12-15

Phase 2

Open-Label Extension Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy

Enrolling by invitationNCT07209332

Wave Life Sciences Ltd.Duchenne Muscular Dystrophy

Start: 2025-12-28End: 2029-03-01Target: 175Updated: 2026-03-06